Detalhe da pesquisa
1.
Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.
Int J Cancer
; 147(1): 170-174, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736068
2.
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland.
Cancer Med
; 10(21): 7759-7771, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34581025
3.
Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.
Clin Infect Dis
; 51(6): 656-62, 2010 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20704493
4.
Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years.
Hum Vaccin Immunother
; 16(6): 1392-1403, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829767
5.
Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of age.
Hum Vaccin
; 5(1): 18-25, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18690013